20118143

Source:http://linkedlifedata.com/resource/pubmed/id/20118143

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:20118143	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:20118143	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:20118143	lifeskim:mentions	umls-concept:C0010346	lld:lifeskim
pubmed-article:20118143	lifeskim:mentions	umls-concept:C1872109	lld:lifeskim
pubmed-article:20118143	lifeskim:mentions	umls-concept:C2003941	lld:lifeskim
pubmed-article:20118143	lifeskim:mentions	umls-concept:C0231491	lld:lifeskim
pubmed-article:20118143	pubmed:issue	2	lld:pubmed
pubmed-article:20118143	pubmed:dateCreated	2010-2-4	lld:pubmed
pubmed-article:20118143	pubmed:abstractText	To review certolizumab pegol for the treatment of moderate-to-severe Crohn's disease (CD).	lld:pubmed
pubmed-article:20118143	pubmed:language	eng	lld:pubmed
pubmed-article:20118143	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20118143	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:20118143	pubmed:month	Feb	lld:pubmed
pubmed-article:20118143	pubmed:issn	1542-6270	lld:pubmed
pubmed-article:20118143	pubmed:author	pubmed-author:DolderChristi...	lld:pubmed
pubmed-article:20118143	pubmed:author	pubmed-author:NelsonMichael...	lld:pubmed
pubmed-article:20118143	pubmed:author	pubmed-author:SmithLisa SLS	lld:pubmed
pubmed-article:20118143	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:20118143	pubmed:volume	44	lld:pubmed
pubmed-article:20118143	pubmed:owner	NLM	lld:pubmed
pubmed-article:20118143	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:20118143	pubmed:pagination	333-42	lld:pubmed
pubmed-article:20118143	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:meshHeading	pubmed-meshheading:20118143...	lld:pubmed
pubmed-article:20118143	pubmed:year	2010	lld:pubmed
pubmed-article:20118143	pubmed:articleTitle	Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease.	lld:pubmed
pubmed-article:20118143	pubmed:affiliation	School of Pharmacy, Wingate University, Wingate, NC, USA. susmith@wingate.edu	lld:pubmed
pubmed-article:20118143	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:20118143	pubmed:publicationType	Review	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:20118143	lld:pubmed